In their study, anti-LIF antibody treatment led to tumor growth suppression and increased survival in mouse models through the reduction of pro-tumoral M2 macrophages and Tregs, as well as the increase of tumor-infiltrating CD8+ T cell and NK cells. This evidence concerns the gene CD8A and neoplasm.